Skip to main content

Table 4 Serum chemistry

From: Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions

Parameter Number of patients Before treatment After treatment Reference range P value Significance
Total bilirubin (μmol/L) 113 1.13 (0.14) 1.09 (0.15) 0.23-1.35 0.002 In normal range but significantly decreased after treatment
Total protein (g/L) 114 65.03 (5.27) 63.20 (6.27) 60.0-85.0 0.002 In normal range but significantly decreased after treatment
Glutamic-pyruvic transaminase, (GPT) (U/L) 114 1.37 (0.22) 1.33 (0.20) 0.7-1.65 0.037 In normal range but significantly decreased after treatment
Glutamic-oxaloacetic transaminase (GOT) (U/L) 114 23.60 (12.45) 21.01 (8.56) 5.0-45.0 0.005 In normal range but significantly decreased after treatment
Serum urea nitrogen (BUN) (μmol/L) 114 4.63 (1.58) 4.58 (1.88) 2.0-7.1 0.750 In normal range, no significant difference
Serum creatinine (SCR) (μmol/L) 114 1.81 (0.16) 1.81 (0.16) 1.64-2.12 0.898 In normal range, no significant difference
Uric acid (UA) (μmol/L) 114 308.27 (80.88) 309.28 (89.64) 90.0-440.0 0.871 In normal range, no significant difference